United States · FDA National Drug Code directory
Cefdinir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-218_9cfbe4a1-045c-489f-8ca7-9d595997dab7
- Product NDC
- 65862-218
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- Cefdinir
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20071214
- Source listing expiry
- 20261231
Source-listed ingredients
- CEFDINIR — 125 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (65862-218-01) / 100 mL in 1 BOTTLE · 65862-218-01
- 1 BOTTLE in 1 CARTON (65862-218-60) / 60 mL in 1 BOTTLE · 65862-218-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →